Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The board of directors of Medtronic, Inc. approved a 9 percent increase in its cash dividend for fiscal year 2010, raising the quarterly amount to 20.5 cents per share of the company’s common stock, for an annual amount of 82 cents per share. In addition, the board approved an increase in its Share Repurchase Plan, authorizing Medtronic to purchase an additional 60 million shares of its common stock, representing approximately 5.4 percent of the company's total basic shares of common stock outstanding during the quarterly period ending April 2009.

Today in Financial Reports...keeping you current

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

Taro Provides Preliminary Third Quarter and Year-to-Date 2009 Financial Results
Taro Pharmaceuticals USA, 12/03/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address